| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1184219C Taxusane phoshponic oxygen methyl ether derivant |
| 01/12/2005 | CN1184206C Prepn process of pyrazole derivative |
| 01/12/2005 | CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841568 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841562 Treatment of gram positive and staphylococcic infections |
| 01/11/2005 | US6841560 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2005 | US6841552 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/06/2005 | WO2005000821A1 Tachykinin receptor antagonists |
| 01/06/2005 | WO2005000815A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 01/06/2005 | WO2005000811A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000809A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 01/06/2005 | WO2005000247A2 4-carboxamido quinoline derivatives for use as nk-2 and nk-3 |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004367 Sulfonamide derivatives |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004166 Imino acid derivatives as inhibitors of matrix metalloproteinases |
| 01/06/2005 | US20050004162 Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004127 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004122 Such as 1(R)-{2,2-Dimethyl-3(R)-[1-(3,4-dichlorophenyl)-3-pyridin-3-yl-1H-pyrazol-5-yl ]cyclobutyl}acetic acid; farnesyl-protein transferase and geranylgeranyl-protein transferase inhibitors |
| 01/06/2005 | US20050004121 Piperazine derivatives; melanin concentrating hormone (MCH) receptor modulators; metabolic and/or eating disorders, diabetes |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004114 Heterocycle substituted carboxylic acids |
| 01/06/2005 | US20050004111 Degenerative joints disease; osteoarthritis |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004104 Methods for the protection of memory and cognition |
| 01/06/2005 | US20050004103 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/06/2005 | US20050004097 Indole derivatives |
| 01/06/2005 | CA2531020A1 Cannabinoid receptor modulator |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1493741A2 Benzo[b]thiophene compounds, intermediates, processes, compositions and methods |
| 01/05/2005 | EP1493740A1 5-fluoro-thiophene compounds, the process for their prepartion, the pharmaceutical compositions containing them and their use as metalloproteinases inhibitors |
| 01/05/2005 | EP1493739A1 Thiophene derivatives of aminoacids, process for the preparation thereof and compositions containing them |
| 01/05/2005 | EP1492786A1 Pyridinoylpiperidines as 5-ht1f agonists |
| 01/05/2005 | EP1492785A1 New compounds |
| 01/05/2005 | EP1492783A1 4,5,6,7-tretrahydrobenzo(b) thiophene derivatives and methods for medical intervention against mycrobacterial infections |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1027051B1 Antithrombotic agents |
| 01/05/2005 | EP1006110B8 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 01/05/2005 | DE10328036A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1561338A Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183116C Substituted isoquinoline derivatives and pharmaceutical composition containing them, its preparation method and use |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/04/2005 | US6838564 Substituted pyridine herbicides |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838465 N-acyltetrahydroisoquinoline derivatives |
| 01/04/2005 | US6838461 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; Huntington's disease; cardiovascular disorders; hypotensive agents; side effect reduction |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6837248 Reduced ignition propensity smoking article |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/04/2005 | CA2293834C Substituted naphthopyrans |
| 01/04/2005 | CA2250929C 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 01/04/2005 | CA2186015C Nicotinic acid derivatives and herbicides |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040266827 Convergent asymmetric route to produce a key intermediate towards the synthesis of a garft inhibitor |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266774 Amide compounds |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | WO2004113328A1 Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a garft inhibitor |
| 12/29/2004 | WO2004113323A1 Quinolyl amide derivatives as ccr-5 antagonists |
| 12/29/2004 | WO2004113320A1 Cannabinoid derivatives, methods of making, and use thereof |
| 12/29/2004 | WO2004113316A1 Benzofuran inhibitors of factor viia |
| 12/29/2004 | WO2004113306A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 12/29/2004 | WO2004113297A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2004 | WO2004112719A2 Chemical compounds |
| 12/29/2004 | WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors |
| 12/29/2004 | WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |